Drug Manufacturers - General
Healthcare16 US-listed companies tracked
Drug manufacturers develop and commercialize pharmaceutical products for treating human diseases and various medical conditions. Their stock performance is shaped by FDA approval success and timelines, patent protection and expiration risk, strong regulatory pricing pressures, and generic drug competition that steadily erodes blockbuster revenues and margins. TrendMatrix ranks 16 US-listed Drug Manufacturers - General stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.
Ranked stocks
| # | Symbol | Score | Verdict | Price | Upside | ||
|---|---|---|---|---|---|---|---|
| HOLD / WATCH | |||||||
| 1 | ABBV | 6.0 | Hold | $256.53 | -2.9% | ||
| 2 | AZN | 5.7 | Hold | $163.00 | +13.6% | ||
| 3 | SNY | 5.6 | Hold | $44.26 | +5.6% | ||
| 4 | BIIB | 5.5 | Hold | $220.90 | -1.3% | ||
| 5 | JNJ | 5.4 | Hold | $276.53 | -9.9% | ||
| 6 | PFE | 5.4 | Hold | $28.44 | -9.5% | ||
| SELL | |||||||
| 7 | LLY | 6.3 | Sell | $1146.65 | +3.0% | ||
| 8 | BMY | 6.2 | Sell | $66.82 | -10.8% | ||
| 9 | AMGN | 6.0 | Sell | $415.00 | -19.8% | ||
| 10 | GRFS | 5.6 | Sell | $7.80 | +18.4% | ||
| 11 | GILD | 5.5 | Sell | $149.77 | -6.2% | ||
| 12 | GSK | 5.5 | Sell | $49.91 | +2.1% | ||
| 13 | NVO | 5.5 | Sell | $46.50 | -12.0% | ||
| 14 | OGN | 5.1 | Sell | $13.78 | -30.6% | ||
| 15 | MRK | 5.0 | Sell | $150.51 | -11.0% | ||
| 16 | NVS | 4.9 | Sell | $152.50 | -14.2% | ||